IGC Announces Issuance of Second Patent for the Treatment of Alzheimer's Using THC - IGC Pharma, INC.

Press

Releases

September 21, 2022

IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC

Related Posts

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

November 3, 2025

IGC Pharma Advances to Semi-Finals in the Alzheimer’s Insights AI Prize with “AHA: Agentic Harmonization Assistant”

October 22, 2025

IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida’s Department of Psychiatry and Behavioral Neurosciences

October 14, 2025

CEO Update

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

November 3, 2025

IGC Pharma Advances to Semi-Finals in the Alzheimer’s Insights AI Prize with “AHA: Agentic Harmonization Assistant”

October 22, 2025